770-25-1-801-0005 - National CMOP LUBRICATING (PF) OPH OINT (VA-25-00008855)
ID: 36C77025Q0013Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Set Aside

Total Small Business Set-Aside (FAR 19.5) (SBA)
Timeline
    Description

    The Department of Veterans Affairs is seeking qualified vendors to provide Lubricating Ophthalmic Ointment for the National Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0013. The procurement requires vendors to submit comprehensive quotes that include a signed RFQ cover page, detailed pricing schedules, proof of licensing, and documentation of authorized dealership status for the products. This contract is crucial for ensuring the availability of essential pharmaceutical products that meet federal regulations, including compliance with the Drug Supply Chain Security Act and FDA standards for therapeutic equivalence. Interested vendors must submit their quotations by October 18, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.

    Point(s) of Contact
    Files
    Title
    Posted
    The government document outlines a Request for Quote (RFQ) for the procurement of medical supplies for the Consolidated Mail Outpatient Pharmacy (CMOP) facilities. The RFQ, designated as 36C77025Q0013, was released on October 11, 2024, with a closing date of October 18, 2024, at 4:00 PM CST. Vendors must submit their quotations via email to a specified contact and provide certain required documents, including a signed solicitation cover page (SF1449) and proof of distributor licensing. Key items for quotation include "Lubricating Ophthalmic Ointment 3.5g" across multiple CMOP locations with specific quantity requirements listed for each facility. Products must have a minimum shelf life of one year upon delivery. Additionally, vendors are asked not to submit more than one quote and to include details such as pricing and expiration dates in their submissions. The document also cautions that certain National Drug Codes (NDCs) are currently not accepted, emphasizing adherence to guidelines for compliant procurement. This RFQ illustrates the government's structured approach to acquiring medical supplies while focusing on regulatory compliance and quality assurance.
    The document outlines a Request for Quotations (RFQ) for a contract from the Department of Veterans Affairs (VA) to procure pharmaceutical products for the National Consolidated Mail Outpatient Pharmacy (CMOP). The requirements specify delivery terms, product specifications, and compliance with federal regulations, including the Drug Supply Chain Security Act. Vendors must submit comprehensive quotes that include a signed RFQ cover page, a detailed pricing schedule, proof of licensing, and documentation proving authorized dealership status for products. The solicitation emphasizes adherence to product labeling standards and therapeutic equivalence approved by the FDA. Additionally, vendors are responsible for managing recalls effectively and ensuring proper shipping methods. Price and availability commitments are required prior to order fulfillment. Delivery timelines are set for ten days after receipt of order (ARO), with specific shipping information designated for multiple CMOP locations. The document serves as a detailed guideline for compliance in responding to the RFP, reinforcing VA's standards for quality and accountability in pharmaceutical procurement.
    The Department of Veterans Affairs (VA), through Network Contracting Office 15, is planning to procure Lubricating Ophthalmic Ointment (3.5g) for multiple Compounding Mail Order Pharmacies (CMOP). The presolicitation notice outlines the solicitation number (36C77025Q0013) with a response deadline of October 18, 2024, at 4 PM Central Time. The contract is set aside for small businesses, focusing on drug and biological products under product service code 6505 and NAICS code 325412 for pharmaceutical preparation manufacturing. Vendors must provide a comprehensive quote including required documentation, such as state wholesale distributor licensure, OEM authorization, and compliance certifications like the Buy American Act Certificate. The estimated issue date for the solicitation is October 11, 2024, with a delivery timeframe of 10 days after the order is received. Submissions must be directed to Contract Specialist Jennifer Knight via email, and timely responses are essential for consideration. This procurement effort reflects the VA's ongoing commitment to supplying necessary pharmaceutical products to enhance health services for veterans.
    Similar Opportunities
    6505--770-24-4-801-0686 -National CMOP CLINDAMYCIN -(VA-24-00096153)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to provide Clindamycin PO4 1% Top Swab for delivery to multiple Compounding Medication Outpatient Pharmacies (CMOP) across the country. This procurement aims to secure approximately 3,584 units of the specified pharmaceutical product, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). The goods are essential for the VA's healthcare services, supporting the treatment of various medical conditions. Interested vendors must submit their quotations by September 6, 2024, including a signed SF1449 cover page, a price schedule, proof of a valid State Wholesale Distributor License, and a Buy American Act Certificate. For further inquiries, vendors can contact Kelley Cunningham at kelley.cunningham@va.gov or call 913-684-0140.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0027 770-25-1-8-1-0015 -National CMOP FENOFIBRATE
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to fulfill an emergency procurement of Fenofibrate pharmaceuticals, specifically 145 mg, under solicitation number 36C77025Q0027. The procurement involves delivering various quantities of the medication to multiple Consolidated Mail Outpatient Pharmacy (CMOP) locations, emphasizing compliance with federal regulations, including the Drug Supply Chain Security Act (DSCSA) and the Buy American Act. This initiative is crucial for ensuring timely access to essential pharmaceuticals for veterans, reflecting the VA's commitment to quality healthcare services. Interested vendors must submit their quotes, along with required documentation, by October 18, 2024, at 9:00 AM Central Time, with an anticipated award date of October 22, 2024. For further inquiries, vendors can contact Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0028 770-25-1-801-0018 -National CMOP METFORMIN HCL
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking quotations for the emergency procurement of Metformin HCL 500mg 24HR SA Tablets, with a presolicitation notice issued under solicitation number 36C77025Q0028. The procurement involves multiple quantities of the medication to be delivered to various VA Consolidated Mail Outpatient Pharmacy (CMOP) locations across the United States, emphasizing the importance of timely and compliant pharmaceutical distribution to meet the needs of veterans. Interested vendors must submit their quotes, including a price schedule in Excel format, proof of state wholesale distributor licensure in compliance with the Drug Supply Chain Security Act, and other required documentation by October 21, 2024, at 09:00 AM CST, with an estimated award date of October 24, 2024. For further inquiries, vendors can contact Michael McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.
    6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.
    6505--Ketoconazole 2% Cream
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the supply of Ketoconazole 2% Cream, a pharmaceutical product essential for treating various skin conditions. Offerors are required to submit pricing for the base year and four option years, ensuring compliance with the Cost Recovery Fee of 0.5%, and must provide unique National Drug Codes (NDC) for their proposed products. This procurement aims to establish a reliable supply chain for pharmaceutical needs while adhering to federal procurement standards, emphasizing the importance of FDA cGMP compliance for manufacturers or authorized distributors. Interested parties should contact Contract Specialist Michael J Olszewski at Michael.Olszewski@va.gov for further details regarding the solicitation process.
    6505--New iDose Contract l STL
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Veterans Health Administration's Network Contracting Office 15, intends to award a sole source firm-fixed price contract for the iDose TR 75MCG Implant, a pharmaceutical product essential for patient care at the St. Louis VA Medical Center. The contract will be awarded to AVEDRO, INC. (Glaukos Corporation) for a total of five one-year ordering periods, under the authority of 41 U.S.C 253(c)(1) FAR 6.302-1, which allows for procurement from a single source when no other suppliers can meet the requirements without unacceptable delays or costs. Interested firms are invited to submit a capabilities statement by October 24, 2024, at 10 AM Central Standard Time, and should direct inquiries to Contracting Officer Janie Juszczak at janie.juszczak@va.gov or by phone at 913-946-1966.
    DA10--**REQUEST FOR INFORMATION** Pharmacy Web-Based Compounding Documentation System VISN 10 Pharmacy Operations
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the VISN 10 Pharmacy Operations, is seeking information regarding a comprehensive web-based compounding documentation system to enhance their pharmacy services. This Request for Information (RFI) aims to identify potential vendors capable of providing a system that meets regulatory standards for compounded sterile preparations, ensuring compliance with guidelines from the United States Pharmacopeia (USP) and other regulatory bodies. The system is intended to support documentation, training, and reporting requirements essential for patient safety and risk mitigation in both sterile and non-sterile compounding environments. Interested parties are encouraged to submit their responses by 1:30 PM EST on October 31, 2024, to Teri Miller at Teri.Miller@VA.gov and Josh Kovar at Joshua.Kovar@VA.gov, ensuring to include their business size and socio-economic categories in their capabilities statement.
    6505--CGRP Calcitonin Gene-Related Peptides
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for a contract to supply Calcitonin gene-related peptides (CGRP) as part of its Pharmaceutical Prime Vendor (PPV) Program. The procurement aims to establish a reliable source of these pharmaceutical products, ensuring compliance with federal regulations, including the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). This initiative is crucial for maintaining consistent supply and quality control across VA medical facilities. Interested offerors must submit their proposals by October 31, 2024, at 2:30 PM CT, and can direct inquiries to Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov.
    6505--Imiquimod 5% Cream and Placebo Manufacturing
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified sources for the manufacturing and supply of Imiquimod 5% Cream and a placebo, as part of a clinical study focused on cancer prevention. This procurement aims to identify capable vendors, particularly Veteran-owned and small businesses, to fulfill the requirements outlined in the attached Request for Information (RFI) and Statement of Work (SOW). The selected contractor will be responsible for adhering to stringent Good Manufacturing Practices and ensuring compliance with federal regulations, including the Non-Manufacturer Rule and Buy American Act, while delivering between 30,000 and 165,000 units annually over a three-year contract period. Interested parties must submit their capabilities statements by November 1, 2024, and can direct inquiries to Contracting Officer Anthony Dela Cruz at anthony.delacruz@va.gov or by phone at 562-766-2284.
    6505--Tadalafil Tablets (VA-24-00107372)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79724R0033 concerning the procurement of Tadalafil Tablets, intended for various federal entities, including the Department of Defense and the Bureau of Prisons. The selected contractor will be responsible for ensuring a continuous supply of Tadalafil, with a contract period of one year and four optional annual extensions, and must adhere to specific labeling and packaging requirements, including safety features for the bottles. This procurement is crucial for meeting the medication needs of veterans and other federal healthcare programs, with an estimated total annual requirement of approximately 322,854 bottles across various strengths. Interested parties should direct inquiries to Contract Specialist Billy Fong at billy.fong@va.gov, and proposals are due by November 12, 2024, following the RFP release on or about October 29, 2024.